Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Linden

Showing results (181-190 of 200) with videos related to

Pageof 20
Sort By:
Archives of Pathology & Laboratory Medicine|June 3, 2006
The CD117 immunohistochemistry tissue microarray survey for quality assurance and interlaboratory comparison: a College of American Pathologists Cell Markers Committee StudyDavid M Dorfman, Marilyn M Bui, Raymond R Tubbs, et al.
Blood|February 2, 2012
In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activationBethan Psaila, James B Bussel, Matthew D Linden, et al.
Journal of Thrombosis and Haemostasis : JTH|November 20, 2009
Targeted inhibition of the serotonin 5HT2A receptor improves coronary patency in an in vivo model of recurrent thrombosisK Przyklenk, A L Frelinger, M D Linden, et al.
Cytometry|January 1, 1991
Concomitant delineation of surface Ig, B-cell differentiation antigens, and HLADR on lymphoid proliferations using three-color immunocytometryG H Segal, M G Edinger, M Owen, et al.
Journal of Thrombosis and Haemostasis : JTH|September 17, 2011
Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopeniaB Psaila, J B Bussel, A L Frelinger, et al.
Journal of Thrombosis and Haemostasis : JTH|September 28, 2006
Evidence that pre-existent variability in platelet response to ADP accounts for 'clopidogrel resistance'A D Michelson, M D Linden, M I Furman, et al.
Blood|February 12, 2005
Platelet activation in cystic fibrosisBrian P O'Sullivan, Matthew D Linden, Andrew L Frelinger, et al.
Thrombosis and Haemostasis|June 29, 2007
The active metabolite of prasugrel inhibits ADP-stimulated thrombo-inflammatory markers of platelet activation: Influence of other blood cells, calcium, and aspirinAndrew L Frelinger, Joseph A Jakubowski, Youfu Li, et al.
The Journal of the Acoustical Society of America|October 15, 2013
Positioning soundscape research and managementTjeerd C Andringa, Miriam Weber, Sarah R Payne, et al.
Lung Cancer (Amsterdam, Netherlands)|April 25, 2003
Suprabasal p53 immunostaining in premalignant endobronchial lesions in combination with histology is associated with bronchial cancerRoderick H J Breuer, Peter J F Snijders, Thomas G Sutedja, et al.
Pageof 20

Showing results (181-190 of 200) with videos related to

Sort By:
Pageof 20
Archives of Pathology & Laboratory Medicine|June 3, 2006
The CD117 immunohistochemistry tissue microarray survey for quality assurance and interlaboratory comparison: a College of American Pathologists Cell Markers Committee StudyDavid M Dorfman, Marilyn M Bui, Raymond R Tubbs, et al.
Blood|February 2, 2012
In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activationBethan Psaila, James B Bussel, Matthew D Linden, et al.
Journal of Thrombosis and Haemostasis : JTH|November 20, 2009
Targeted inhibition of the serotonin 5HT2A receptor improves coronary patency in an in vivo model of recurrent thrombosisK Przyklenk, A L Frelinger, M D Linden, et al.
Cytometry|January 1, 1991
Concomitant delineation of surface Ig, B-cell differentiation antigens, and HLADR on lymphoid proliferations using three-color immunocytometryG H Segal, M G Edinger, M Owen, et al.
Journal of Thrombosis and Haemostasis : JTH|September 17, 2011
Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopeniaB Psaila, J B Bussel, A L Frelinger, et al.
Journal of Thrombosis and Haemostasis : JTH|September 28, 2006
Evidence that pre-existent variability in platelet response to ADP accounts for 'clopidogrel resistance'A D Michelson, M D Linden, M I Furman, et al.
Blood|February 12, 2005
Platelet activation in cystic fibrosisBrian P O'Sullivan, Matthew D Linden, Andrew L Frelinger, et al.
Thrombosis and Haemostasis|June 29, 2007
The active metabolite of prasugrel inhibits ADP-stimulated thrombo-inflammatory markers of platelet activation: Influence of other blood cells, calcium, and aspirinAndrew L Frelinger, Joseph A Jakubowski, Youfu Li, et al.
The Journal of the Acoustical Society of America|October 15, 2013
Positioning soundscape research and managementTjeerd C Andringa, Miriam Weber, Sarah R Payne, et al.
Lung Cancer (Amsterdam, Netherlands)|April 25, 2003
Suprabasal p53 immunostaining in premalignant endobronchial lesions in combination with histology is associated with bronchial cancerRoderick H J Breuer, Peter J F Snijders, Thomas G Sutedja, et al.
Pageof 20